Searched over 200M research papers
6 papers analyzed
These studies suggest that low-dose lisinopril-hydrochlorothiazide combination effectively reduces blood pressure and is well-tolerated.
20 papers analyzed
L-Arginine Supplementation
L-arginine, an amino acid and a substrate of nitric oxide synthase, has been studied for its potential blood pressure-lowering effects. A meta-analysis of randomized, double-blind, placebo-controlled trials demonstrated that oral L-arginine supplementation significantly lowers both systolic and diastolic blood pressure. Specifically, L-arginine reduced systolic blood pressure by an average of 5.39 mm Hg and diastolic blood pressure by 2.66 mm Hg compared to placebo. This suggests that L-arginine could be a beneficial supplement for managing hypertension.
L-Arginine in Pregnancy
In a study involving pregnant women with chronic hypertension, L-arginine supplementation did not significantly change overall blood pressure but was associated with a reduced need for antihypertensive medications and a trend towards fewer maternal and neonatal complications. This indicates that while L-arginine may not drastically lower blood pressure in pregnant women, it could still offer protective benefits.
Lisinopril Monotherapy
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly used to treat hypertension. A large multicenter study evaluated the antihypertensive effects of lisinopril alone and in combination with hydrochlorothiazide. The study found that lisinopril effectively reduced blood pressure in patients with mild to moderate hypertension. The combination of lisinopril with hydrochlorothiazide provided even greater blood pressure reduction without significant metabolic side effects.
Combination Therapy with Lisinopril
The combination of lisinopril and hydrochlorothiazide was shown to be more effective than either drug alone. This combination therapy significantly lowered both systolic and diastolic blood pressure, making it a potent option for patients requiring more aggressive blood pressure management.
L-Name Induced Hypertension Studies
Studies on L-NAME (Nω-Nitro-L-arginine methyl ester) induced hypertension in rats have explored the effects of various medications, including aliskiren, telmisartan, and torsemide. These studies found that all three drugs significantly decreased blood pressure compared to L-NAME alone. However, telmisartan and aliskiren were more effective than torsemide in reducing blood pressure and cardiac fibrosis. While these studies are preclinical, they provide insights into the potential efficacy of these medications in managing hypertension.
Medications and supplements starting with "L," such as L-arginine and lisinopril, have shown significant potential in managing hypertension. L-arginine supplementation can lower blood pressure and reduce the need for antihypertensive medications in specific populations, such as pregnant women. Lisinopril, particularly in combination with hydrochlorothiazide, offers robust blood pressure control with minimal side effects. Further research and clinical trials will continue to elucidate the full benefits and optimal use of these treatments in hypertension management.
Most relevant research papers on this topic